Key Success Factors for Hiring People with Disabilities

THE HARTFORD’S ABILITY PHILOSOPHY is grounded in the belief that people are defined by what they can do, not by what they can’t. With the right support and resources, every person can navigate past obstacles in their daily lives to achieve personal and business goals.

Spotlight

Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc. headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. and a member of the Daiichi Sankyo Group. Global clinical development and regulatory activities are headquartered at Daiichi Sankyo Pharma Development in Edison, New Jersey.

OTHER WHITEPAPERS
news image

2023 State of Cybersecurityfor Medical Devices andHealthcare Systems

whitePaper | August 7, 2023

Improving patient safety and protecting healthcare from cybersecurity threats is our top priority at Health-ISAC. The healthcare sector is essential to a country’s national security infrastructure. Cyber-attacks on healthcare systems can have broader implications for public health and national security.

Read More
news image

2022 Healthcare Cyber Crime Update

whitePaper | August 12, 2022

Amid a growing array of threats, the healthcare industry is pummeled by hundreds of successful cyber attacks each year. Ransomware, business email compromise (BEC) and state-sponsored attacks are just a few of the threats that keep security teams awake at night.

Read More
news image

Rethinking Indicators of Project Success in Healthcare

whitePaper | March 4, 2020

Health leaders must understand the benefits of their investments in performance improvement projects and the impact on the organization. The traditional approach is most often to measure ROI (return on investment) and, while clearly measurable, is most often related to cost savings or increased revenue and can leave you with an incomplete story. Incorporating VOI (value on investment) enables you to quantify the intangible benefits of your projects and activities making the combination of the two a more robust indicator of project success.

Read More
news image

As patient care channels become more fragmented, communications & coordination can become integrated

whitePaper | June 30, 2022

A platform approach to clinical communications keeps clinicians connected and patient data more secure

Read More
news image

Health and Human Services Commission CFO Reference Guide

whitePaper | January 1, 2023

The Health and Human Services Commission’s Chief Financial Officer division is proud to offer the first edition of The Health and Human Services Commission CFO Reference Guide: An Overview of Key Financial Topics.

Read More
news image

The Rise of Hybrid Clinical Trials

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.

Read More

Spotlight

Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc. headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. and a member of the Daiichi Sankyo Group. Global clinical development and regulatory activities are headquartered at Daiichi Sankyo Pharma Development in Edison, New Jersey.

Events